Brian Bressler

12.1k total citations · 3 hit papers
237 papers, 7.8k citations indexed

About

Brian Bressler is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Brian Bressler has authored 237 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Genetics, 139 papers in Epidemiology and 61 papers in Surgery. Recurrent topics in Brian Bressler's work include Inflammatory Bowel Disease (166 papers), Microscopic Colitis (126 papers) and Eosinophilic Esophagitis (22 papers). Brian Bressler is often cited by papers focused on Inflammatory Bowel Disease (166 papers), Microscopic Colitis (126 papers) and Eosinophilic Esophagitis (22 papers). Brian Bressler collaborates with scholars based in Canada, United States and United Kingdom. Brian Bressler's co-authors include Greg Rosenfeld, William J. Sandborn, Brian G. Feagan, Bruce E. Sands, Richard N. Fedorak, Paul Rutgeerts, Jean‐Frédéric Colombel, Stephen B. Hanauer, Lawrence Paszat and Linda Rabeneck and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Brian Bressler

222 papers receiving 7.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

2013 2.0k citations William J. Sandborn, Brian G. Feagan et al. profile →
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

2015 311 citations Yvette Leung, Jennifer Jones et al. Gastroenterology profile →
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

2019 228 citations Adam S. Cheifetz, Gil Melmed et al. profile →

Peers

Countries citing papers authored by Brian Bressler

Since Specialization

Citations

This map shows the geographic impact of Brian Bressler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Bressler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Bressler more than expected).

Fields of papers citing papers by Brian Bressler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Bressler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Bressler. The network helps show where Brian Bressler may publish in the future.

Co-authorship network of co-authors of Brian Bressler

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Bressler. A scholar is included among the top collaborators of Brian Bressler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Bressler. Brian Bressler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gut microbiome predictors of advanced therapy response in Crohn’s disease: protocol for the OPTIMIST prospective, longitudinal, observational pilot study in Canada 2025 ·BMJ Open ·(unknown), Susanna Meade, (unknown), Gurpreet Kaur, Brian Bressler, Greg Rosenfeld, Yvette Leung, (unknown), (unknown)	4
2	P0371 Building a Robust Artificial Intelligence Solution for Use in Ulcerative Colitis Clinical Trials 2025 ·Journal of Crohn s and Colitis ·Michelle L. Byrne, James Requa, Julián Panés, Brian Bressler, Remo Panaccione, (unknown), (unknown), Nasim Parsa, Rupa Banerjee, Rakesh Kalapala, D. Nageshwar Reddy, (unknown), (unknown), Gordon W. Moran, (unknown), Vincent Cheung, (unknown), Christopher Ma, Simon Travis, Vipul Jairath	1
3	Crohn’s Disease Phenotypes and Associations With Comorbidities, Surgery Risk, Medications and Nonmedication Approaches: The MAGIC in IMAGINE Study 2024 ·Inflammatory Bowel Diseases ·Çharles N. Bernstein, Remo Panaccione, Zoann Nugent, Deborah A. Marshall, Gilaad G. Kaplan, Stephen Vanner, Levinus A. Dieleman, Lesley A. Graff, Anthony Otley, Jennifer Jones, Michelle Buresi, Sanjay K. Murthy, Mark Borgaonkar, Brian Bressler, Alain Bitton, Kenneth Croitoru, Sacha Sidani, Aida Fernandes, Paul Moayyedi	1
4	Patient and Provider Perspectives on Telemedicine use in Canadian Gastroenterology Clinics during the COVID-19 pandemic: A Survey study 2024 ·(unknown), (unknown), (unknown), (unknown), Eric Lam, Robert Enns, Brian Bressler, (unknown)	0
5	Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn’s Disease 2024 ·Inflammatory Bowel Diseases ·Reena Khanna, Brian G. Feagan, Guangyong Zou, Larry Stitt, John WD McDonald, Brian Bressler, Remo Panaccione, Lisa M. Shackelton, (unknown), Edward V. Loftus, Marco Daperno, Vipul Jairath, Geert D’Haens, William J. Sandborn	2
6	Bile acid–induced metabolic changes in the colon promote Enterobacteriaceae expansion and associate with dysbiosis in Crohn’s disease 2024 ·Science Signaling ·(unknown), Haggai Bar‐Yoseph, (unknown), Antonio Serapio-Palacios, Kyung‐Mee Moon, R. Greg Stacey, Katherine Donald, Wanyin Deng, Brian Bressler, Armando Alcázar Magaña, Leonard J. Foster, (unknown), James D. Johnson, B. Brett Finlay	0
7	Practical guidance for managing patients with moderate-to-severe ulcerative colitis using small molecule therapies 2024 ·Journal of the Canadian Association of Gastroenterology ·Vipul Jairath, Waqqas Afif, Brian Bressler, Janet Pope, Daniel Selchen, Laura E. Targownik, Remo Panaccione	2
8	759 THE EFFICACY AND SAFETY OF GUSELKUMAB AS MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR MAINTENANCE STUDY 2024 ·Gastroenterology ·David T. Rubin, Jessica R. Allegretti, Julián Panés, (unknown), Shadi Yarandi, Kuan‐Hsiang Gary Huang, Matthew Germinaro, (unknown), Hongyan Zhang, Brian G. Feagan, Tadakazu Hisamatsu, Gary R. Lichtenstein, Brian Bressler, Laurent Peyrin‐Biroulet, Bruce E. Sands, Axel Dignaß	14
9	902 TOFACITINIB FOR HOSPITALIZED ACUTE SEVERE ULCERATIVE COLITIS - THE TRIUMPH STUDY 2024 ·Gastroenterology ·Neeraj Narula, Farhad Peerani, Tawnya Hansen, Talat Bessissow, Brian Bressler, (unknown), (unknown), (unknown), John Marshall	1
10	Sa1151 MUCOSAL HEALING WITH VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH CHRONIC POUCHITIS: EVIDENCE FROM EARNEST, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 2023 ·Gastroenterology ·Vipul Jairath, Brian G. Feagan, Mark S. Silverberg, Silvio Danese, Paolo Gionchetti, Mark Löwenberg, Brian Bressler, Marc Ferrante, Ailsa Hart, Dirk Lindner, (unknown), Stephen E. Jones, Bo Shen, Simon Travis	1
11	Impact of Telehealth on Medication Adherence in Chronic Gastrointestinal Diseases 2022 ·Journal of the Canadian Association of Gastroenterology ·(unknown), (unknown), (unknown), Eric Lam, Robert Enns, Brian Bressler, (unknown)	6
12	International Perspectives on Management of Inflammatory Bowel Disease: Opinion Differences and Similarities Between Patients and Physicians From the IBD GAPPS Survey 2021 ·Inflammatory Bowel Diseases ·David T. Rubin, Charles A. Sninsky, Britta Siegmund, Miquel Sans, Ailsa Hart, Brian Bressler, Yoram Bouhnik, Alessandro Armuzzi, Anita Afzali	54
13	Innate Control of Tissue-Reparative Human Regulatory T Cells 2019 ·The Journal of Immunology ·(unknown), Katherine N. MacDonald, Anne M. Pesenacker, S. Juvet, Kimberly Morishita, Brian Bressler, James Pan, Sachdev S. Sidhu, John D. Rioux, Megan K. Levings	36
14	Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open 2019 ·Alimentary Pharmacology & Therapeutics ·Bruce E. Sands, Alessandro Armuzzi, John K. Marshall, James O. Lindsay, William J. Sandborn, Silvio Danese, Julián Panés, Brian Bressler, Jean‐Frédéric Colombel, Nervin Lawendy, Eric S. Maller, Haiying Zhang, Gary Chan, Leonardo Salese, (unknown), Amy Marren, Chinyu Su	65
15	P583. Real-world use and effectiveness of golimumab for ulcerative colitis in Canada 2016 ·Journal of Crohn s and Colitis ·(unknown), Fabienne Charbit‐Henrion, Cécilia Landman, Harry Sokol, Anne Bourrier, Isabelle Nion–Larmurier, Jacques Cosnes, Laurent Beaugerie, Philippe Seksik, Brian Bressler, Martin Williamson, Fernando Camacho, (unknown), A. Hillary Steinhart	1
16	The Utility of Infliximab Therapeutic Drug Monitoring among Patients with Inflammatory Bowel Disease and Concerns for Loss of Response: A Retrospective Analysis of a Real-World Experience 2016 ·Canadian Journal of Gastroenterology and Hepatology ·Robert A. Mitchell, (unknown), Neal Shahidi, (unknown), Mari L. DeMarco, (unknown), Robert Enns, Brian Bressler	17
17	Pediatric Inflammatory Bowel Disease Among South Asians Living in British Columbia, Canada 2016 ·Inflammatory Bowel Diseases ·Matthew Carroll, Zachary Hamilton, (unknown), (unknown), Matthew D. Smyth, V. Espinosa, Brian Bressler, Kevan Jacobson	16
18	DOP042. Clinical response and remission with vedolizumab across a range of baseline fecal calprotectin levels in ulcerative colitis: Results from GEMINI 1 2015 ·Journal of Crohn s and Colitis ·Walter Reinisch, James D. Lewis, Themistocles Dassopoulos, Philip Ginsburg, B E Sands, Brian G. Feagan, Silvio Danese, Arne Røseth, Maria Rosario, Huyuan Yang, A. Parikh, Brian Bressler, Timothy Wyant	2
19	A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis 2012 ·Gut ·Paul Rutgeerts, Richard N. Fedorak, Daan W. Hommes, Andreas Sturm, Daniel C. Baumgart, Brian Bressler, Stefan Schreiber, John Mansfield, Marna Williams, Meina Tang, Jennifer Visich, Xiaohui Wei, Mary Keir, Diana Luca, Dimitry M. Danilenko, Jackson G. Egen, Sharon O’Byrne	111
20	Current Controversies in Crohn's Disease: A Roundtable Discussion of the BRIDGe Group. 2008 ·PubMed Central ·Miles Sparrow, Peter M. Irving, Leonard Baidoo, Brian Bressler, Adam S. Cheifetz, Shane Devlin, Laura Harrell, Jennifer Jones, Patricia Kozuch, Gil Melmed, Fernando Velayos, Corey A. Siegel	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact